Navigation Links
VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution
Date:12/7/2009

WAYNE, Pa., Dec. 7 /PRNewswire-FirstCall/ -- VitaminSpice (OTC Bulletin Board: VTMS)(German WKN: A0YCND) VitaminSpice announces that it has signed an agreement with Bill Fields' consulting firm, Fields Texas Unlimited, for introducing their products into the US market. VitaminSpice (www.VitaminSpice.net) holds a privileged position as being first-to-market with their line of vitamin-enhanced spices, utilizing a proprietary micro-encapsulation process.

CEO Ed Bukstel commented, "Mr. Fields' experience in retail in North America is unparalleled and will give VitaminSpice immediate credibility with all the major chains and distributors throughout the US and Canada."

Bill Fields has recently joined the VitaminSpice Board of Directors, and is standing behind this commitment with the vast support and resources of Intersource Enterprises, in a bid to capture a share of the increasingly wealthy Chinese market as well as the US market through Fields Texas Unlimited. Mr. William R. Fields is Chairman of Intersource Enterprises Ltd., and China Horizons Management Ltd. Previously, Mr. Fields served as Chairman and Chief Executive Officer of Factory 2-U Stores, Inc. from 2002 to 2003, President and Chief Executive Officer of Hudson's Bay Company from 1997 to 1999 and as Chairman and Chief Executive Officer of Blockbuster Entertainment Group, a division of Viacom, Inc., from 1996 to 1997. Mr. Fields has also held numerous positions with Wal-Mart Stores, Inc., which he joined in 1971. He left Wal-Mart in March 1996 as President and Chief Executive Officer of Wal-Mart Stores Division, and Executive Vice President of Wal-Mart Stores, Inc.

About VitaminSpice

VitaminSpice is uniquely positioned between the $100 billion health food/vitamin supplement industry and the multi-trillion-dollar traditional food industry. A pioneer in the emerging foodceutical industry, VitaminSpice sells vitamin- mineral- and antioxidant-infused spices and food products. Their offerings currently include Crushed Red Pepper, Ground Black Pepper, Sea Salt, Italian Seasoning, Ground Cinnamon and Granulated Garlic. A proprietary micro-encapsulation process keeps the vitamin properties locked inside--even when heated--allowing the food products to retain their full flavor.

For additional news and information on VitaminSpice, contact Ed Bukstel ebukstel@vitaminspice.net, (610) 994-1657 or visit www.VitaminSpice.net.

VitaminSpice Safe Harbor

This News Release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.


Contact

VitaminSpice LLC
Ed Bukstel, ph. (610) 994-1657
ebukstel@vitaminspice.net

VitaminSpice Investor Relations
Doug Wetzel, ph. (308) 385-4991

SOURCE VitaminSpice LLC


'/>"/>
SOURCE VitaminSpice LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VitaminSpice Elects Bill Fields to the Board of Directors
2. VitaminSpice Signs MOU With Seamless Corp. for Sale of VitaminSpice Product Line on the Seamless Websites
3. Nationally Known Psychotherapist Dr. Robi Ludwig Joins Qualsecs Wholly-Owned Subsidiary VitaminSpice
4. Pot bellies linked to early signs of cardiovascular disease
5. MSU engineering team designs innovative medical device
6. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
7. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
8. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
9. A new technology for cancer screening listens for the signs of cancer
10. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: